TD
Timothy Daley Wells Fargo Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Qiagen
QGEN
$9.98B
| $46.01 | $46.68 |
1%
upside
| Equal-Weight |
19 Dec ‘23
1 year ago |
|
2
Myriad Genetics
MYGN
$642M
| $6.90 | $20 |
190%
upside
| Equal-Weight |
19 Dec ‘23
1 year ago |
|
3
Revvity
RVTY
$9.58B
| $82.50 | $95 |
15%
upside
| Equal-Weight |
19 Dec ‘23
1 year ago |
|
4
Bruker
BRKR
$4.63B
| $30.49 | $72 |
136%
upside
| Equal-Weight |
19 Dec ‘23
1 year ago |
|
5
Agilent Technologies
A
$35.2B
| $124.12 | $145 |
17%
upside
| Overweight |
22 Nov ‘23
1 year ago |
|
6
Mettler-Toledo International
MTD
$25.8B
| $1,252.87 | $1,300 |
4%
upside
| Overweight |
13 Nov ‘23
1 year ago |
|
7
Waters Corp
WAT
$17.4B
| $293.03 | $285 |
3%
downside
| Equal-Weight |
8 Nov ‘23
1 year ago |
|
8
Danaher
DHR
$138B
| $192.59 | $247 |
28%
upside
| Overweight |
3 Oct ‘23
1 year ago |
|
9
Charles River Laboratories
CRL
$7.54B
| $153.27 | $275 |
79%
upside
| Overweight |
22 Sep ‘23
1 year ago |
|
10
Labcorp
LH
$22.7B
| $272.94 | $270 |
1%
downside
| Overweight |
14 Aug ‘23
2 years ago |
|
11
Neogen
NEOG
$1.21B
| $5.59 | $28 |
401%
upside
| Overweight |
14 Aug ‘23
2 years ago |
|
12
Stevanato
STVN
$7.05B
| $25.84 | $35 |
35%
upside
| Overweight |
31 Jul ‘23
2 years ago |
|
13
Thermo Fisher Scientific
TMO
$180B
| $476.54 | $520 |
9%
upside
| Underweight |
28 Jul ‘23
2 years ago |
|
14
Inotiv
NOTV
$47.8M
| $1.39 | $9 |
547%
upside
| Overweight |
20 Jul ‘23
2 years ago |
|
15
Repligen
RGEN
$6.76B
| $120.23 | $185 |
54%
upside
| Overweight |
20 Jul ‘23
2 years ago |
|
16
Hologic
HOLX
$14.6B
| $65.50 | $85 |
30%
upside
| Equal-Weight |
2 May ‘23
2 years ago |
|
17
IQVIA
IQV
$31.3B
| $183.87 | $220 |
20%
upside
| Equal-Weight |
1 May ‘23
2 years ago |
|
18
Icon
ICLR
$12.9B
| $165.44 | $220 |
33%
upside
| Equal-Weight |
1 May ‘23
2 years ago |
|
19
Avantor
AVTR
$8.6B
| $12.61 | $28 |
122%
upside
| Overweight |
8 Feb ‘23
2 years ago |
|
20
Quest Diagnostics
DGX
$20.1B
| $180.14 | $140 |
22%
downside
| Equal-Weight |
3 Feb ‘23
2 years ago |
|
21
Bio-Techne
TECH
$7.93B
| $50.96 | $90 |
77%
upside
| Equal-Weight |
10 Jan ‘23
2 years ago |
|